Skip to main content
Log in

Effect of a Hydroalcoholic Extract of Rosa Canina Flowers on Anxiety in Rats

  • Published:
Neurophysiology Aims and scope

We investigated effects of the hydroalcoholic extract of Rosa сanina (dog rose) petals on behavior of rats in the elevated plus-maze (EPM) test; adult male Wistar rats weighing 200-240 g were used. Oral everyday administration of the Rosa extract in three doses (150, 300, and 450 mg/kg) was done for one week. Animal behavior in the EPM was videotaped for 10 min, and conventional indices considered to be related to the anxiety level were scored. Introduction of the Rosa canina extract significantly increased the number of open arm entries in a dose-dependent manner and also increased the time of stay in the open arms at a high dose (450 mg/kg). At the same time, the number of closed arm entries interpreted as a correlate of the locomotion intensity did not differ from the control at all doses. Thus, the Rosa canina extract, when orally administered, demonstrates an anxiolytic profile in rats. Future investigations are essential for better understanding of the anxiolytic properties of the extract and neurobiological mechanisms of its action (probable interactions of the Rose extract active agents with neurotransmitter systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. S. Pellow, “Anxiolytic and anxiogenic drug effects in a novel test of anxiety: Are exploratory models of anxiety in rodents valid?” Methods Find. Exp. Clin. Pharmacol., 8, 557-565 (1986).

    CAS  PubMed  Google Scholar 

  2. H. I. Kaplan and B. J. Sadoch, Comprehensive Textbook of Psychiatry (8th Edn.), Williams and Wilkins, Baltimore (2005).

    Google Scholar 

  3. M. Lader and S. Morton, “Benzodiazepine problems,” Br. J. Addict., 86, 823-828 (1991).

    Article  CAS  PubMed  Google Scholar 

  4. R. R. Griffiths, N. A. Ator, J. D. Roache, and R. J. Lamb, “Abuse liability of triazolam: Experimental measurements in animals and humans,” Psychopharmacology, No. 3, 83-87 (1987).

  5. O. Grundmann, J. Nakajima, S. Seo, and V. Butterweck, “Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test,” J. Ethnopharmacol., 2007 Apr 4;110(3):406-11. Epub 2006 Oct 13.

  6. W. Bussmann Rainer, S. Paul, W. Aserat, and E. Paul, “Plant use in Odo-Bulu and Demaro Bale Region, Ethiopia,” J. Ethnobiol. Ethnomed. , 7, 28-81 (2011).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. A. Rezaie, Gh. Mosavi, Ch. Ahmadizadeh, and B. Jafari, “Study of sedative, preanaesthetic and anti-anxiety effects of Rosa damascene herbal extract in comparison with diazepam in rat,” Tehran Univ. Med. J., 69, No. 3, 179-184 (2011).

    Google Scholar 

  8. A. Haji Sharif, Herbal Secrets - Version healing (1), Tehran (in Persian). (2007).

  9. A. Zargari, Medicinal Plants, Vol: 2, Tehran University Publication, Tehran (in Persian). (1989).

  10. O. Nilson., “Rose,” in: Flora of Turkey and the East Aegean Islands, P. H. Davis, ed., Edinburgh University Press, Edinburgh, 106-128 (1997).

  11. S. Kazaz, H. Baydar, and S. Erbas, “Variations in chemical compositions of Rosa damascene Mill and Rosa canina L. fruits,” Czech J. Food Sci., 27, 178-184 (2009).

    CAS  Google Scholar 

  12. S. Ercisli, “Chemical composition of fruits in some rose (Rosa spp.) species,” Food Chem., 104, No. 4, 1379- 1384 (2007).

    Article  CAS  Google Scholar 

  13. E. Rein, A. Kharazmi, G. Thamsbprg, and K. Winther, “A herbal remedy, made from a subspecies of rosehip Rosa canina, reduces symptoms of knee and hip osteoarthritis,” Osteoarthritis Cart., 12, Suppl. 2, S80- S80 (2004).

    Google Scholar 

  14. O. Warholm, S. Skaar, E. Hedman, et al., “The effects of a standardized herbal remedy made from a subtype of Rosa canina in patients with osteoarthritis: A doubleblind, randomized, placebo-controlled clinical trial,” Curr. Ther. Res. Clin. Exp. , 64, No. 1, 21-31 (2003).

    Article  PubMed Central  PubMed  Google Scholar 

  15. R. Lister, “The use of a plus-maze to measure anxiety in the mouse,” Psychopharmacology, 92, 180-185 (1987).

    CAS  PubMed  Google Scholar 

  16. S. P. Pellow and S. Chopin, “Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat,” J. Neurosci. Methods, 14, 149-167 (1985).

    Article  CAS  PubMed  Google Scholar 

  17. A. Komaki, Z. Khaledi Nasab, S. Shahidi, et al., “Anxiolytic effects of acute injection of hydro-alcoholic extract of lettuce in the elevated plus-maze task in rats,” Avicenna J. Neuro Psycho Physiol., 1, No.1, e18695 (2014).

  18. D. N. Stephens and J. S. Andrews, “Screening for anxiolytic drugs,” in: Behavioral Models in Psychopharmacology (P. Willner, ed.), Cambridge Univ. Press, Cambridge (1991), pp. 50-75.

  19. S. Hogg, “A review of the validity and variability of the elevated plus-maze as an animal model of anxiety,” Pharmacol. Biochem. Behav., 54, 21-30 (1996).

    Article  CAS  PubMed  Google Scholar 

  20. S. Pellow and S. E. File, “Anxiolytic and anxiogenic drug effects on exploratory activity in elevated plusmaze: A novel test of anxiety in the rat,” Pharmacol. Biochem. Behav., 24, 525-529 (1986).

    Article  CAS  PubMed  Google Scholar 

  21. A. Komaki, F. Abdollahzadeh, A. Sarihi, et al., “Interaction between antagonist of cannabinoid receptor and antagonist of adrenergic receptor on anxiety in male rat,” Basic Clin. Neurosci., 5, No.3, 218-24 (2014).

  22. M. H. Lader, “Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?,” Eur. Neuropsychopharmacol., 9 (Suppl. 6), 399-405 (1999).

    Article  Google Scholar 

  23. R. R. Griffiths, N. A. Ator, J. D. Roache, and R. J. Lamb, “Abuse liability of triazolam: Experimental measurements in animals and humans,” Psychopharmacology, 3, 83-87 (1987).

    CAS  Google Scholar 

  24. M. Holm., “One year follow-up of users of benzodiazepines in general practice,” Dan. Med. Bull., 37, 188-191 (1990).

  25. A. Chevallier, The Encyclopedia of Medicinal Plants, Dorling-Kindersley, London, 171 (1996)

  26. A. Begossi, N. Hanazaki, and N. Peroni, “Knowledge and use of bodiversity in Brazilian hot spots,” Environ. Dev. Sustain., 2, 177-193 (2001).

    Article  Google Scholar 

  27. L. Chunlin, L. Sumei, L. Bo, et al., “Medicinal plants used by the Yi ethnic group: A case study in central Yunnan,” J. Ethnobiol. Ethnomed ., 5, 13-18 (2009).

  28. M. Shalit, I. Guterman, H.Volpin, et al., “Volatile ester formation in roses, identification of an acetyl-coenzyme A. Geraniol/Citronellol acetyltransferase in developing rose petals,” Plant Physiol., 131, 1876-1888 (2003).

  29. K. Hosni, A. Kerkenni, W. Medfei, et al., “Volatile oil constituents of Rosa canina L.: Quality as affected by the distillation method,” Hindawi Publ. Corp. Org. Chem. Int., ID 621967, 7, (2010).

  30. H. Ghazghazi, M. G. Miguel, B. Hasnaoui, et al., “Phenols, essential oils and carotenoids of Rosa canina from Tunisia and their antioxidant activities,” Afr. J. Biotechnol., 9, No. 18, 2709-2716 (2010).

    CAS  Google Scholar 

  31. G. Buchbauer, L. Jirovetz, W. Jäger, et al., “Aromatherapy: evidence for sedative effects of the essential oil of lavender after inhalation,” Z. Naturforsch. [C], 46, 1067-1072 (1991).

  32. E. Elisabetsky, G. P. Coelho de Souza, M. A. C. Dos Santos, et al., “Sedative properties of linalool,” Fitoterapia, 5, 407-414 (1995).

    Google Scholar 

  33. F. N. Souto-Maior, F. L Carvalho, L. C. Morais, et al., “Anxiolytic-like effects of inhaled linalool oxide in experimental mouse anxiety models,” Pharmacol. Biochem. Behav., 100, 259-263 (2011).

  34. E. Elizabetsky, J. Marschner, and D. O. Souza, “Effects of linalool on glutamatergic system in the rat cerebral cortex,” Neurochem. Res., 20, 461-465 (1995)

    Article  Google Scholar 

  35. E. Sofic, A. Copra-Janicijevic, M. Salihovic, et al., “Screening of medicinal plant extracts for quercetin- 3-rutinoside (rutin) in Bosnia and Herzegovina,” Med. Plants, 2, No. 2, 97-102 (2010).

  36. T. Fujii and M. Saito, “Inhibitory effect of quercetin isolated from rose hip (Rosa canina L.) against melanogenesis by mouse melanoma cells,” Biosci. Biotechnol. Biochem., 73, No. 9, 1989-1993(2009).

  37. A. Priprem, J. Watanatorn, S. Sutthiparinyanont, et al., “Anxiety and cognitive effects of quercetin liposomes in rats,” Nanomedicine, 4, No. 1 70-78 (2008).

  38. S. J. Pravinkumar, G. Edwards, D. Lindsay, et al., “A cluster of Legionnaires’ disease caused by Legionella longbeachae linked to potting compost in Scotland, 2008-2009,” Eurosurveillance, 15, No. 8, pii = 19496. pmid:20197024 (2010).

  39. B. F. Bradley, N. J. Starkey, S. L. Browna, R.W. Lea, “Anxiolytic effects of Lavandula angustifolia odour on the Mongolian gerbil in elevated plus maze,” J. Ethnopharmacol., 111, 517-525 (2007).

    Article  CAS  PubMed  Google Scholar 

  40. P. Bhutada, Y. Mundhada, K. Bansod, et al., “Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice,” Prog. Neuropsychopharmacol. Biol. Psychiatr., 34, No. 6, 955-960 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Komaki.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nemati, Z., Komaki, A., Shahidi, S. et al. Effect of a Hydroalcoholic Extract of Rosa Canina Flowers on Anxiety in Rats. Neurophysiology 47, 133–137 (2015). https://doi.org/10.1007/s11062-015-9509-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11062-015-9509-y

Keywords

Navigation